ARCHIVE
ID Number: FT-21-5731



This research is provided for historical perspective;
portions of this document may not reflect current conditions.






Oracle's Bid for PeopleSoft: Update 25 November
25 November 2003
 
Betsy Burton   Bruce Bond   Jeff Comport   Yvonne Genovese   Brian Zrimsek   Lee Geishecker  

With its tender offer for PeopleSoft, Oracle is attempting to gain more control over broader markets. Gartner advises how this offer could affect you.









Browse Topics


Other Options







Contact Gartner






Download Document:

PDF

oracles_bid_for...pdf (47.8KB)

Help with Downloads




News Analysis




Event

As of 25 November 2003, the latest developments in Oracle's unsolicited bid to acquire PeopleSoft include:

  • On 17 November 2003, the European Commission announced it would make a detailed investigation of Oracle's bid for PeopleSoft. The Commission must issue its final decision by March 2004.
  • On 10 November 2003, Oracle asked the Delaware Court of Chancery to expedite its request for an injunction against PeopleSoft's customer assurance program, stating that the "poison pill" provision could force it to withdraw its offer.
  • On 6 November 2003, PeopleSoft shareholders filed a motion in the Delaware Court of Chancery, challenging PeopleSoft's customer assurance program.
  • On 23 October 2003, PeopleSoft announced its 3Q03 financial results. Excluding the impact of purchase accounting from the company's acquisition of J.D. Edwards, PeopleSoft posted a profit of $0.17 per share, 6 cents above analyst expectations. With costs of the J.D. Edwards acquisition included, PeopleSoft posted a net loss of 2 cents per share.
  • On 14 October 2003, IT industry media reported that Oracle extended the deadline for its bid to buy PeopleSoft for $19.50 per share from 17 October 2003 to 31 December 2003.



Analysis

Oracle has reiterated its intention to pursue its bid for PeopleSoft as recently as 24 November 2003. However, the bid is in limbo until the U.S. Department of Justice rules on its antitrust inquiry into the deal. The European Commission can't block the acquisition completely, but can determine how the parties will have to operate in Europe. Gartner anticipates no developments that will substantially alter the situation before this ruling. When the Justice Department will conclude its inquiry is unknown, but it could possibly stretch for months beyond December 2003. Meanwhile, we expect PeopleSoft and Oracle will continue with legal, marketing and financial moves to advance their respective positions. Oracle will likely reiterate that it is pursuing the bid and that success is just a matter of time; PeopleSoft will likely insist that Oracle's bid has failed and that PeopleSoft has moved on. PeopleSoft's 3Q03 financial performance shows that the company has been able to focus on business as usual, but at this time the 3Q03 numbers will not directly affect Oracle's bid.

PeopleSoft will continue business as usual, with joint PeopleSoft and J.D. Edwards teams working on product road maps (see "PeopleSoft's New Strategy Depends on Cross-Selling, Service Goals"). As it pushes out its latest release of its E-Business Suite, Oracle will continue to make moves on legal and financial fronts to remove the significant hurdles it faces in completing the deal. We see nothing on the immediate horizon to indicate a lessening of these hurdles. To fully develop an opinion on the potential effects of Oracle's bid, you should consider all the elements that could affect the outcome of this action. Specific elements at play include:

Factors Working in PeopleSoft's Favor

  • The impact of PeopleSoft’s customer assurance program. This recently revised program promises to pay between two and five times a customer's software license fees if PeopleSoft is acquired within two years and if the buyer reduces product support within four years. For Oracle, this ongoing program represents nearly $800 million in potential liability and has led the company to ask the Delaware Court to speed its ruling on an injunction against the customer assurance program. If the program continues, Oracle has stated that it may be forced to abandon its takeover effort.
  • PeopleSoft’s poison pill provision. As part of PeopleSoft’s stock plan, if a hostile buyer (such as Oracle) acquires 20 percent of the common shares, the so-called poison pill will be triggered. This trigger provides all PeopleSoft shareholders, excluding Oracle, with approximately 21 shares for each PeopleSoft share they own, thereby diluting the shares tendered to Oracle.
  • The deal price. Oracle’s current offer is $19.50 per PeopleSoft share. PeopleSoft shares hit a high of $22.69 on 7 November 2003.
  • The expanded and staggered terms of the PeopleSoft's board of directors. Replacing a majority of the board would take at least two years.

Factors Working in Oracle's Favor

  • A shareholder lawsuit challenging the customer assurance program. This program is targeted to meet PeopleSoft customers' best interests. However, a group of shareholders feels that its terms are "disproportionate and unreasonable,” citing that the plan could not be reversed by PeopleSoft's board, even if the company's shareholders accepted a takeover offer.

Factors That Could Work in Favor of Either Vendor

  • The United States Department of Justice ruling. The Antitrust Division of the U.S. Department of Justice is expected to rule on its inquiry by mid-December 2003 at the earliest. This saga may extend into February 2004.
  • The European Commission ruling. The European Commission, the European Union’s enforcement body, announced it would make a detailed investigation of Oracle's bid for PeopleSoft. The Commission must issue its final decision by March 2004.
  • PeopleSoft’s financial results. Continued positive financial results work in favor of PeopleSoft; negative results will work in favor of Oracle.
  • The willingness of PeopleSoft’s board to accept Oracle’s bid. The pivotal question is, what price will change the minds of the board?

Until the Justice Department rules on this case, Gartner continues to advise clients considering PeopleSoft and J.D. Edwards offerings to use Gartner's decision frameworks to determine their strategy. We have updated these frameworks to reflect recent developments. The frameworks yield different advice, depending on each client's view of whether the Oracle deal will be completed and whether product delivery will be disrupted, balanced with the client's risk tolerance (see "Short-Term Advice for PeopleSoft Customers and Prospects" and "Short-Term Advice for J.D. Edwards Customers, Prospects"). Clients aiming to sign strategic software agreements with these vendors (and in general) should include best-in-class terms, conditions and policies that protect their software investments, particularly in areas such as support, upgrades, migration and service (see "Contractual Protections for PeopleSoft Customers").

For Further Information and Research

Gartner continues to work on research related to the individual markets affected and the impact on customers of other vendors. We encourage clients to review our current research, and if you have specific questions, talk with your Gartner analyst — by phone (United States +1 203 316 1266, Europe +44 1784 267770) or e-mail (bizapps@gartner.com, euro.inquiry@gartner.com). Gartner offers the following research:









Browse Topics:
 





© 2003 Gartner, Inc. and/or its Affiliates. All Rights Reserved. Reproduction and distribution of this publication in any form without prior written permission is forbidden. The conclusions, projections and recommendations represent Gartner's initial analysis. As a result, our positions are subject to refinements or major changes as Gartner analysts gather more information and perform further analysis. Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner's research may discuss legal issues related to the information technology business, Gartner does not provide legal advice or services and its research should not be construed or used as such. Gartner shall have no liability for errors, omissions or inadequacies in the information contained herein or for interpretations thereof. The opinions expressed herein are subject to change without notice.




Resource Id: 416882